Thus, we performed flow cytometric analysis to confirm that almost all CD215+ cells in the tumor and spleen of NSI tumor-bearing mice are CD45+ CD11b+ Gr-1+ myeloid cells (Figure S2A,B Supplementary Material). This evidence concerns the gene PTPRC and neoplasm.